Your browser doesn't support javascript.
loading
Neural tissue tolerance to synthetic dural mater graft implantation in a rabbit durotomy model.
Ramot, Yuval; Kronfeld, Noam; Steiner, Michal; Manassa, Nora Nseir; Bahar, Amir; Nyska, Abraham.
Afiliação
  • Ramot Y; Department of Dermatology, Hadassah Medical Center, PO Box 12000, Jerusalem, 9112001, Israel.
  • Kronfeld N; The Faculty of Medicine, Hebrew University of Jerusalem, PO Box 12272, Jerusalem, 9112001, Israel.
  • Steiner M; Envigo CRS (Israel), Einstein St., Building 13B, Weizmann Science Park, Ness Ziona, 7414001, Israel.
  • Manassa NN; Department of Dermatology, Hadassah Medical Center, PO Box 12000, Jerusalem, 9112001, Israel.
  • Bahar A; Pre-Clinical Consultant, Carmel St. 11/22, Rehovot, 7630511, Israel.
  • Nyska A; Nurami Medical Nanofiber Technology, Ha-Namal St 36, Haifa, 303203, Israel.
J Toxicol Pathol ; 37(2): 83-91, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38584968
ABSTRACT
In neurosurgical interventions, effective closure of the dura mater is essential to prevent cerebrospinal fluid leakage and minimize post-operative complications. Biodegradable synthetic materials have the potential to be used as dura mater grafts owing to their regenerative properties and low immunogenicity. This study evaluated the safety of ArtiFascia, a synthetic dura mater graft composed of poly(l-lactic-co-caprolactone acid) and poly(d-lactic-co-caprolactone acid), in a rabbit durotomy model. Previously, ArtiFascia demonstrated positive local tolerance and biodegradability in a 12-month preclinical trial. Here, specialized stains were used to evaluate potential brain damage associated with ArtiFascia use. Histochemical and immunohistochemical assessments included Luxol Fast Blue, cresyl Violet, Masson's Trichrome, neuronal nuclei,, Glial Fibrillary Acidic Protein, and ionized calcium-binding adaptor molecule 1 stains. The stained slides were graded based on the brain-specific reactions. The results showed no damage to the underlying brain tissue for either the ArtiFascia or control implants. Neither inflammation nor neuronal loss was evident, corroborating the safety of the ArtiFascia. This approach, combined with previous histopathological analyses, strengthens the safety profile of ArtiFascia and sets a benchmark for biodegradable material assessment in dura graft applications. This study aligns with the Food and Drug Administration guidelines and offers a comprehensive evaluation of the potential neural tissue effects of synthetic dura mater grafts.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Toxicol Pathol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Israel

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Toxicol Pathol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Israel